Epilepsy Trial, Recruiting (NCT04302116)

Epilepsy Trial, Recruiting NCT04302116 Sponsor: Kullasate Sakpichaisakul Condition: Epilepsy

Printed from Voxsanity (voxsanity.com.au) — NCT04302116 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Epilepsy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The baby is between 2 and 14 months old at the time of joining the trial
A specialist children's brain doctor has diagnosed the baby with infantile spasms, and a specialist has confirmed a specific unusual brainwave pattern on a brain activity test (EEG)
The baby is a Thai national

Who may not be able to join:

The baby has received the medications vigabatrin or corticosteroids in the last 28 days
The baby has previously been diagnosed with certain serious brain conditions present from very early in life (confirm with trial site)
The baby is suspected of having or has been diagnosed with a condition called tuberous sclerosis complex, which may be indicated by things such as an affected parent, certain skin markings, tumours on the heart, eye findings, or kidney cysts (confirm with trial site)
The baby has a medical reason why they cannot safely take vigabatrin or corticosteroids, such as a recent chickenpox or shingles infection, or bleeding in the stomach or intestines (confirm with trial site)
The baby's parents or guardians are not able to understand instructions or information given in Thai
The family is unlikely to be able to attend the required follow-up appointments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kullasate Sakpichaisakul, MD, Queen Sirikit National Institute of Child Health

Phone: 66-2-354-8333

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04302116

Sponsor: Kullasate Sakpichaisakul

Phase: Not Applicable

Status: Recruiting

Condition: Epilepsy

Trial contact: 66-2-354-8333

More information: https://clinicaltrials.gov/study/NCT04302116

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The baby is between 2 and 14 months old at the time of joining the trial
A specialist children's brain doctor has diagnosed the baby with infantile spasms, and a specialist has confirmed a specific unusual brainwave pattern on a brain activity test (EEG)
The baby is a Thai national

Who may not be able to join:

The baby has received the medications vigabatrin or corticosteroids in the last 28 days
The baby has previously been diagnosed with certain serious brain conditions present from very early in life (confirm with trial site)
The baby is suspected of having or has been diagnosed with a condition called tuberous sclerosis complex, which may be indicated by things such as an affected parent, certain skin markings, tumours on the heart, eye findings, or kidney cysts (confirm with trial site)
The baby has a medical reason why they cannot safely take vigabatrin or corticosteroids, such as a recent chickenpox or shingles infection, or bleeding in the stomach or intestines (confirm with trial site)
The baby's parents or guardians are not able to understand instructions or information given in Thai
The family is unlikely to be able to attend the required follow-up appointments

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Kullasate Sakpichaisakul

Registry

ClinicalTrials.gov

Start date

18 May 2020

Est. completion

1 June 2026

Where this trial is recruiting

🇹🇭 Thailand

Primary endpoints

Cessation of spasms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov